Patients with peripheral arterial disease (PAD) often have multifocal atherosclerotic lesions and substantial comorbidities that increase their operative risk. Limb revascularization previously required lengthy and sometimes staged procedures that were associated with increased morbidity and mortality. The advent of endovascular techniques changed the management of many PAD lesions.

Multiple studies have demonstrated the benefits of endovascular therapy for superficial femoral artery (SFA) occlusive disease [1] - [7] . However, unlike superficial femoral artery atherosclerotic disease, lesions in the common femoral artery (CFA) require special consideration with regard to endovascular treatment. Studies utilizing endovascular therapy for CFA occlusive disease have demonstrated variable results [8] -[11] . The anatomical location of CFA atherosclerotic disease precludes sole endovascular therapy. Lesions are often bulky, eccentric, and located at branch points, preventing ipsilateral access and stent deployment [12] . Stent placement across the inguinal ligament can lead to stent fracture and occlusion from intimal hyperplasia [13] . Furthermore, stent placement for CFA disease can sacrifice collaterals provided by the profunda and complicate future surgeries [13] . Studies have demonstrated that endarterectomy remains the standard of care for CFA occlusive disease [13] [14] .

Recently, hybrid techniques for multifocal atherosclerotic disease have gained popularity [15] - [24] . These procedures use the proven durability of common femoral endarterectomy with concomitant endovascular management for both inflow and outflow lesions. As a result, multivessel disease can be treated in one procedure, without major hemodynamic changes, minimal blood loss, and limited risk of perioperative complications [16] .

One limitation of common femoral endarterectomy is the ability to tack down unsafe distal flaps. With severe atherosclerotic disease, an incomplete endarterectomy may be performed for fear that the flap may be located too far distally to be safely tacked down with sutures, or a longer arteriotomy has to be made in order to create a safe endpoint for the endarterectomy. In our study, we employed a hybrid technique utilizing stent grafts to stabilize the distal flap in a location not amenable to suture tacking, allowing a more extensive common femoral and superficial femoral endarterectomy to be performed.

All patients at Monmouth Medical Center in Long Branch, NJ that underwent a femoral endarterectomy combined with the placement of a stent to stabilize the distal flap from September 2008 to March 2013 were included in this study. Procedures with stent placement not used to stabilize the distal flap were not included. The age, sex, type of stent, presenting complaints, and complications were evaluated.

Isolation of the common femoral, superficial femoral, and profunda arteries was first carried out. A guidewire was placed distally and kept there throughout the procedure (Figure 1). Remote endarterectomy was then carried out using a Vollmar Ring Dissector [LeMaitre Vascular] (Figure 2). A Viabahn stent (GORE VIABAHN

Endoprosthesis, expanded polytetrafluoroethylene (ePTFE) liner attached to an external nitinol stent) was then deployed in the proximal SFA, under direct supervision, without the aid of fluoroscopy. The proximal end of the stent is positioned to be deployed at the distal end of the arteriotomy (Figure 3). After completion of the endarterectomy (Figure 4), a Bovine pericardium patch was then used to repair the arteriotomy (Figure 5). A completion arteriogram was then performed in cases where fluoroscopy was needed for treatment of other lesions (Figure 6).

There were a total of 15 patients that underwent femoral endarterectomy with distal flap stent placement. Twelve patients underwent endarterectomy for debilitating claudication and three for limb salvage. The average age was 75 years. Sixty percent were female. Five patients had an additional stent placed proximally in the external iliac artery to increase inflow. One patient had an additional stent placed distally to increase outflow. Technical success was achieved in all patients without any intraoperative or postoperative complications.

Endarterectomy has long been the standard of care for common femoral artery occlusive disease, achieving over 90% immediate technical success rate [13] [14] . Many sources have demonstrated long term results for common femoral endarterectomy [13] [14] [25] . Ballotta et al. demonstrated in a 7-year study that the primary patency, primary-assisted patency, and limb salvage rates after CFA endarterectomy was 96%, 100%, and 100%, respectively [14] . Kang et al. also reported over 90% patency rates at a mean follow up of 27 months [13] . These authors concluded that endarterectomy should remain the standard of care for CFA occlusive disease [13] [14] .

Recent studies involving solely endovascular treatment for CFA lesions are conflicting [8] - [11] . Bonvini et al. analyzed 360 consecutive percutaneous interventions of the CFA for atherosclerotic disease [8] . Balloon angioplasty was performed as the primary intervention in virtually all cases, while 36.9% of procedures required a stent for suboptimal angioplasty [9] . Angiography demonstrated >30% residual post-procedure stenosis in 7.2% [9] . Medium-term follow-up at one year showed restenosis >50% in 27.6% and target lesions revascularization in 19.9% [9] . Soga et al. evaluated endovascular therapy for CFA and demonstrated a 1- and 5-year primary patency rate of 73.4% and 46.9%, respectively [10] . Dattilo et al. showed more promising results in their study of 31 CFA endovascular procedures, with technically success in 90% of cases and an overall 1-year primary and secondary patency rate of 88% and 92%, respectively [11] .

Despite the somewhat successful short- and medium-term results of endovascular therapy, there are many surgeons who are opposed to the procedure. Common femoral artery stenting prevents future endovascular access, makes distal bypass surgery difficult, and may sacrifice collaterals from the profunda artery [13] [14] . Furthermore, placing a stent across a joint or the inguinal ligament predisposes it to fracture and intimal hyperplasia [13] [14] [18] .

The recent evolution of hybrid procedures, utilizing open and endovascular techniques, obviates the risks associated with CFA stenting and has gained increasing popularity in treating multifocal disease [15] - [24] . One advantage of the hybrid procedure is the ability to treat more complex anatomy using less invasive procedures in patients considered high medical risk [16] . Patent inflow and outflow can be achieved with endovascular techni- ques through the same arteriotomy, using limited surgical exposure. This can also be done under local anesthesia

for high risk patients. Furthermore, with limited exposure, there is a decreased risk of an infection. Many sources have reported on the results of hybrid procedures in the treatment of common femoral artery occlusive disease. Chang et al. presented 171 patients who underwent common femoral endarterectomy combined with the placement of iliac stents or stent grafts with 5-year primary, primary assisted, and secondary patencies of 60%, 97%, and 98%, respectively [17] . Hayes et al. combined femoral endarterectomy with distal femoral-popliteal stent graft placement to avoid traditional femoral-popliteal bypass [18] . Piazza et al. evaluated patients with extensive iliac and common femoral occlusive disease by comparing open reconstruction to a hybrid approach [19] . They reported similar short- and long-term efficacy with the hybrid technique and recommended this approach in high-risk patients [19] .

In our study, we employed a hybrid technique that allowed a more extensive endarterectomy to be performed, compared to conventional endarterectomy, while still maintaining safety by deploying a stent graft to stabilize the distal flap. Traditionally, the distal flaps are tacked down using sutures to prevent further dissection [12] . However, in most patients the disease progresses into the SFA [14] with no clear transition point, leaving a distal flap that is difficult to safely tack down. Feng et al. reported the largest study of 104 cases of common femoral endarterectomy combined with SFA stenting for chronic lower extremity ischemia over three years [12] . The authors performed an endarterectomy, tacked the distal flap using sutures, and then placed a stent proximal to the distal endarterectomy edge to avoid an intimal edge flap [12] . We were able to perform a more extensive endarterectomy using the Vollmar Ring Dissector (LeMaitre Vascular) to the point where the distal flap was not visualized in the SFA and, therefore, not amenable to suture tacking. Use of a stent graft at this location provided a safe transition to the true lumen not possible with suture tacking. Furthermore, the stent graft was deployed under direct visualization without the need for fluoroscopy.

This study has several limitations. The data used in this study was retrospectively collected from a single institution, resulting in a small number of cases. Second, this study did not assess for long-term efficacy results. Despite these limitations, our study describes a novel hybrid technique where a more extensive CFA endarterectomy can be performed using the Vollmar Ring Dissector with distal flap stabilization via stenting.

Endarterectomy is still the standard of care for common femoral artery occlusive disease. We employed a hybrid technique where a stent graft was used to stabilize the distal flap. Stent graft placement allows a more extensive endarterectomy to be performed by stabilizing the distal flap allowing a safe transition into the true lumen that is not possible with suture tacking.